Skip to Content

New Drug Approvals Archive - September 2013

September 2013

Abraxane (paclitaxel protein-bound)

New Indication Approved: September 6, 2013

Read more: Abraxane (paclitaxel protein-bound) FDA Approval History

Botox Cosmetic (onabotulinumtoxinA)

New Indication Approved: September 11, 2013

Trintellix (vortioxetine) Tablets - formerly Brintellix

Date of Approval: September 30, 2013
Company: Takeda Pharmaceutical Company Limited and H. Lundbeck A/S
Treatment for: Depression

Trintellix (vortioxetine) is a multimodal antidepressant for the treatment of major depressive disorder (MDD).

Read more: Trintellix (vortioxetine) FDA Approval History

New Drug Approvals Archive